SC&H Financial Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$347K Hold
1,327
– – 0.05% 112
2026
Q2
$334K Hold
1,327
– – 0.04% 122
2026
Q1
$289K Hold
1,327
– – 0.04% 126
2025
Q4
$303K Buy
1,327
+151
+13% +$34.4K 0.05% 126
2025
Q3
$272K Buy
1,176
+7
+0.6% +$1.43K 0.04% 125
2025
Q2
$217K Hold
1,169
– – 0.04% 146
2025
Q1
$245K Sell
1,169
-30
-3% -$5.83K 0.05% 132
2024
Q4
$213K Buy
1,199
+30
+3% +$5.52K 0.04% 143
2024
Q3
$231K Buy
1,169
+2
+0.2% +$373 0.05% 138
2024
Q2
$200K Buy
+1,167
New +$193K 0.05% 141

Other funds holding ABBV

SC&H Financial Advisors's ABBV Position: Q3 2026 in Review

SC&H Financial Advisors held its AbbVie (ABBV) position steady in Q3 2026 at 1,327 shares worth $347K. The position accounts for 0.05% of the portfolio, ranked #112.

SC&H Financial Advisors first reported a position in ABBV in Q2 2024 and has held it in 10 quarters since. 534 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • SC&H Financial Advisors held 1,327 shares of AbbVie worth $347K as of Q3 2026.
  • SC&H Financial Advisors left its AbbVie share count unchanged in Q3 2026.
  • AbbVie made up 0.05% of SC&H Financial Advisors's portfolio in Q3 2026, its #112 holding.
  • SC&H Financial Advisors first reported a position in AbbVie in Q2 2024 and has held it in 10 quarters since.
  • 534 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on SC&H Financial Advisors's 13F filing for Q3 2026, filed 14 Oct 2026.